Eli Lilly & Co. (LLY)

NYSE

$1,163.11

$+14.04

(+1.23%)

Regular Market

Eli Lilly & Co. (LLY) Live Price Chart

Last updated: ⁦2026-10-05 14:02:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Eli Lilly & Co. (LLY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $1,163.11, with a market capitalisation of $1.02T and a P/E ratio of 38.14. Over the past 52 weeks, its price has ranged from $783.85 to $1,292.65. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.02T
Open	$1,150.76
Day's High	$1,292.65
Day's Low	$27.21
Previous Close	$1,142.85
Volume	265.15K
Average Volume	2.50M
P/E Ratio	38.14
52-Week High	$1,292.65
52-Week Low	$783.85
Dividend Yield	0.57%
Earnings Date	--

Eli Lilly & Co. (LLY) Stock Price Today

Eli Lilly & Co. (LLY) is currently trading at $1,163.11 as of 2026-10-05 13:46:50, up 1.77% ($20.26) from the previous close of $1,142.85

During today's regular trading session, LLY has traded between $27.21 and $1,292.65, with a trading volume of 265.15K shares. The current price is near the upper end of today's range.

Eli Lilly & Co. (LLY) 7-Day Stock Price Change

Over the past seven days, Eli Lilly & Co. (LLY) moved from $1,181.89 to $1,163.11, representing a decline of 1.59% ($18.79).

The stock traded between $1,136.66 and $1,215.00 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 2.23 million shares, down versus the previous seven-day period, indicating lower trading activity.

LLY 52-Week Price Position

Position in Range: 74.5%

52W Low$783.85

52W High$1,292.65

LLY is currently trading at $1,163.11, placing it 74.5% of the way from its 52-week low of $783.85 to its 52-week high of $1,292.65. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Eli Lilly & Co. (LLY)?

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Eli Lilly & Co. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	50000
Exchange	NYSE
Company Website	https://www.lilly.com

How to Buy Eli Lilly & Co. (LLY) Stock on MEXC

Eligible investors can buy real shares of Eli Lilly & Co. (LLY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for LLY and Place Your Order

Open the RealStocks trading page and search for LLY. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Eli Lilly & Co. (LLY) stock price today?

Eli Lilly & Co. (LLY) is currently trading at $ 1,163.11, up 1.77% ($20.26) from the previous close of $ 1,142.85. Intraday prices update in real time during regular trading hours.

2.Is LLY stock going up or down today?

As of 2026-10-05 13:46:50, LLY is trading at $ 1,163.11, up 1.77% ($20.26) from its previous close of $ 1,142.85. The stock has traded between $ 27.21 and $ 1,292.65 during today’s regular session. Past price movements do not guarantee future results.

3.What is LLY pre-market price?

As of 2026-10-05 13:46:50, LLY is trading at $ 1,143.50 in pre-market trading, up 0.06% ($0.65) from the previous close of $ 1,142.85. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is LLY after-hours price?

As of 2026-10-05 13:46:50, LLY is trading at $ 1,144.00 in after-hours trading, up 0.10% ($1.15) from the regular-session close of $ 1,142.85. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is LLY stock trading now?

LLY trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does LLY sit relative to its 52-week high and low?

Over the past 52 weeks, LLY has traded between a low of $ 783.85 and a high of $ 1,292.65. At $ 1,163.11, the stock is positioned 74.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Eli Lilly & Co. in?

Eli Lilly & Co. (LLY) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Eli Lilly & Co.'s market capitalisation and where is it listed?

Eli Lilly & Co. is listed on the NYSE exchange with a market capitalisation of $ 1.02T. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is LLY valued in terms of P/E ratio and EPS?

LLY trades at a P/E ratio of 38.14, based on trailing-twelve-month EPS of $ 29.97. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Eli Lilly & Co. pay a dividend?

Eli Lilly & Co. pays an indicated annual cash dividend of $ 6.63 per share, with a current dividend yield of 0.57% based on the latest share price. Dividend policies are subject to change at the board's discretion.